SFA Therapeutics Receives Grant For Drug for Acute Respiratory Distress Syndrome In COVID-19
Excerpt from the press release:
“PHILADELPHIA – June 24, 2020 – PRLog — SFA Therapeutics, Inc. is pleased to announce receipt of a “Save Our Start-ups” (SOS) grant to study SFA005 in the treatment of cytokine storm linked to Acute Respiratory Distress Syndrome (ARDS), which has been experienced by patients infected with COVID-19. This grant was issued by Ben Franklin Technology Partners and the Commonwealth of Pennsylvania.”
Click the button below to read the press release:
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?